Cerapedics is a Broomfield, Colo.-based orthobiologics company.
Here are five observations:
1. Michael Janssen, DO, of Denver-based Spine Education Research Institute, led the research.
2. The trial demonstrated the i-FACTOR bone graft was safe and effective. It met FDA-mandated non-inferiority success criteria in comparison to local autograft in single-level ACDF for cervical radiculopathy.
3. The i-FACTOR bone graft and autograft had high fusion rates in the study and showed improvements in neck disability index.
4. The i-FACTOR bone graft exhibited a 69 percent success rate in all four primary outcomes, while the autograft demonstrated a 57 percent success rate.
5. The researchers concluded the i-FACTOR bone graft is a strong alternative to autograft bone for ACDF procedures.
More articles on spine:
6 key notes on spinal fusion complications & length of stay
Drs. Ralph G. Dacey Jr., Dawn Tartaglione & more: 13 spine surgeons recently receiving honors — Feb. 8, 2016
Society of Neurological Surgeons names Dr. Ralph Dacey president: 4 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
